Clioquinol, Metal chelator and ionophore

Alternative names

28 kDa heat shock protein, ACLS, AHDC, AHR_HUMAN, AI838772, AIS, ALDC, ALDH 1, ALDH 11, ALDH class 1, ALDH class 2, ALDH-E1, ALDH-E2, ALDHI, ALDM, ALHDII, ANDR_HUMAN, AP-1, AR, AR8, ARO, ARO1, AW493413, Acetaldehyde dehydrogenase 1, Acetaldehyde dehydrogenase 2, Activator protein 1, Ah receptor, Aldehyde dehydrogenase 1, Aldehyde dehydrogenase 1 family member A1, Aldehyde dehydrogenase 1 soluble, Aldehyde dehydrogenase 1A1, Aldehyde dehydrogenase 2 family, Aldehyde dehydrogenase 2 family (mitochondrial), Aldehyde dehydrogenase cytosolic, Aldehyde dehydrogenase liver cytosolic, Aldehyde dehydrogenase mitochondrial, Aldh, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Antigen NY-CO-13, Aromatase, Aromatic hydrocarbon receptor, Aryl hydrocarbon receptor, Aryl hydrocarbon receptor precursor, Atherosclerosis, susceptibility to, included, BAR, BAZ2B_HUMAN, BCC7, BXR, Bile acid receptor, Bromodomain adjacent to zinc finger domain 2B, Bromodomain adjacent to zinc finger domain protein 2B, CA 1, CA 12, CA 13, CA 14, CA 2, CA 7, CA IV, CA VA, CA-I, CA-II, CA-IX, CA-VI, CA-VII, CA-XII, CA-XIII, CA-XIV, CA13 carbonic anhydrase XIII, CA4, CA5, CA6, CA9, CAB, CAC, CAH12_HUMAN, CAH13_HUMAN, CAH14_HUMAN, CAH1_HUMAN, CAH2_HUMAN, CAH4_HUMAN, CAH6_HUMAN, CAH7_HUMAN, CAH9_HUMAN, CAV, CMT1A, CMT1E, CMT2F, CP19A_HUMAN, CPV1, CYAR, CYP19, CYPXIX, Car 1, Car 2, Car4, Carbonate dehydratase I, Carbonate dehydratase II, Carbonate dehydratase IV, Carbonate dehydratase IX, Carbonate dehydratase VA, Carbonate dehydratase VI, Carbonate dehydratase VII, Carbonate dehydratase XII, Carbonate dehydratase XIII, Carbonate dehydratase XIV, Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13, Carbonic anhydrase 14, Carbonic anhydrase 2, Carbonic anhydrase 4, Carbonic anhydrase 6, Carbonic anhydrase 7, Carbonic anhydrase 9, Carbonic anhydrase A, Carbonic anhydrase B, Carbonic anhydrase B, formerly, Carbonic anhydrase C, Carbonic anhydrase C, formerly, Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase IX, Carbonic anhydrase VA, Carbonic anhydrase VA mitochondrial, Carbonic anhydrase VI, Carbonic anhydrase VII, Carbonic anhydrase XII, Carbonic anhydrase XIII, Carbonic anhydrase XIV, Carbonic dehydratase, Carbonic dehydratase IV, Carbonic dehydratase VII, Cellular tumor antigen p53, Class E basic helix-loop-helix protein 76, Cyp19a1, Cytochrome P-450AROM, Cytochrome P450 19A1, Cytochrome P450, family 19, subfamily A, polypeptide 1, Cytochrome P450, subfamily XIX (aromatization of androgens), DHTR, DKFZp434H071, DKFZp586P1322, DKFZp686N23123, DKFZp762I0516, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), EC 4.2.1.1, EC=4.2.1.1, ECK0125, ER, ER-alpha, ER-beta, ERK-2, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ERT1, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Enhancer Binding Protein AP1, Epididymis secretory protein Li 282, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen synthase, Estrogen synthetase, Estrogen-regulated 24 kDa protein, Estrogen-related receptor alpha, Estrra, Extracellular signal-regulated kinase 2, FLJ11090, FLJ20151, FLJ45644, FLJ92943, Farnesoid X-activated receptor, Farnesol receptor HRR-1, GAS-3, GCCR, GCPS, GCRST, GCR_HUMAN, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, GR, GUSTIN, Glioma associated oncogene family zinc finger 3, Glucocorticoid receptor, Grl1, Growth Arrest Specific 3, Growth arrest-specific protein 3, HDL cholesterol, augmented response of, to hormone replacement, included, HEL-76, HEL-S-102, HEL-S-282, HGNC:348, HMN2B, HMSNIA, HNPP, HRR 1, HS.76067, HS90A_HUMAN, HSP 27, HSP 84, HSP 86, HSP 90, HSP 90 b, HSP90A, HSP90AA1, HSP90AB1, HSPB1_HUMAN, HSPC1, HSPC2, HSPCAL1, HSPCAL4, HUMARA, HYSP1, Heat Shock Protein 27, Heat shock 25kDa protein 1, Heat shock 27 kDa protein, Heat shock 27kD protein 1, Heat shock 27kDa protein 1, Heat shock 28kDa protein 1, Heat shock 86 kDa, Heat shock protein 90kDa alpha cytosolic class A member 1, Heat shock protein 90kDa alpha cytosolic class B member 1, Heat shock protein HSP 90-alpha, Heat shock protein HSP 90-beta, Heat shock protein beta-1, HsT18816, Hsp 25, Hsp 28, IMD42, JUN protein, JUNC, JUN_HUMAN, JW0122, Jun Activation Domain Binding Protein, Jun oncogene, Jun proto oncogene, K-OR-1, KD, Kappa opioid receptor, Kappa-type opioid receptor, Kennedy disease (KD), LFS1, Liver mitochondrial ALDH, MAP kinase 1, MAP kinase 2, MAP kinase isoform p42, MAPK 1, MGC104252, MGC104309, MGC112732, MGC129539, MGC1806, MGC20769, MGC21256, MGC2318, MK01_HUMAN, MN, Membrane antigen MN, Microsomal monooxygenase, Mitochondrial aldehyde dehydrogenase 2, Mitogen-activated protein kinase 1, Mitogen-activated protein kinase 2, Mutant tumor protein 53, Myocardial infarction, susceptibility to, included, NR1B1, NR1F3, NR1I2_HUMAN, NR3A1, NR3A2, NR3B1, NR3C3, NR3C4, Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group B member 1, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, Nuclear receptor subfamily 3 group C member 3, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form, Nucleus encoded mitochondrial aldehyde dehydrogenase 2, ONR 1, OPRK 1, OPRK_HUMAN, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000162543, OTTHUMP00000162897, OTTHUMP00000162898, OTTHUMP00000198350, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Oncogene GLI3, Oncogene JUN, Opiate receptor kappa 1, Opioid receptor, kappa 1, Oprk2, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, P 450AROM, P38, P41, P53_HUMAN, P54/58N, PAP A, PAPB, PAR, PAR q, PGR, PMP22_HUMAN, PPD IV, PR, PRA, PRB, PRGR_HUMAN, PRKM 2, PRKM1, PRR, PUMB 1, Peripheral myelin protein 22, Phosphoprotein p53, Pregnane X receptor, Progesterone receptor, Progestin receptor form A, Progestin receptor form B, Proto-oncogene c-jun, R21, RALDH 1, RAR, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-alpha, RAR-related orphan receptor C, RARA_HUMAN, RARalpha1, RCC associated protein G250, RCC-associated antigen G250, RIP 14, RNESTROR, RORG_HUMAN, RP17, RP24-311F12.2, RXR-interacting protein 14, RZR GAMMA, RZRG, Renal carcinoma antigen NY-REN-38, Renal cell carcinoma-associated antigen G250, Retinal dehydrogenase 1, Retinaldehyde dehydrogenase 1, Retinitis pigmentosa 17 (autosomal dominant), Retinoic acid binding receptor gamma, Retinoic acid nuclear receptor alpha variant 1, Retinoic acid nuclear receptor alpha variant 2, Retinoic acid receptor alpha, Retinoic acid receptor alpha polypeptide, Retinoid X receptor-interacting protein 14, Retinoid-related orphan receptor-gamma, Rorc, SBMA, SCAN1, SMAX1, SRP27, SXR, Salivary carbonic anhydrase, Secreted carbonic anhydrase, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, Stress-responsive protein 27, T18816, TFM, TOR, TRP53, TYDP, TYDP1_HUMAN, Testicular Feminization (TFM), Tp53, Transcription factor AP-1, Transcriptional activator GLI3, Transcriptional repressor GLI3R, Transformation related protein 53, Trembler, Tumor antigen HOM-RCC-3.1.3, Tumor protein 53, Tumor protein p53, Tumor suppressor p53, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, UNQ690/PRO1335, V jun sarcoma virus 17 oncogene homolog, V jun sarcoma virus 17 oncogene homolog (avian), V-jun avian sarcoma virus 17 oncogene homolog, WALp4, Zinc finger protein GLI 3, androgen receptor splice variant 4b, bHLHe76, cJun, carbonic anhydrase 5A mitochondrial, carbonic anhydrase V mitochondrial, carbonic anhydrase VA mitochondrial1, carbonic anhydrase VI nirs variant 1, carbonic anhydrase VI nirs variant 3, epididymis luminal protein 76, epididymis secretory protein Li 102, estrogen receptor related receptor alpha, flavoprotein-linked monooxygenase, glucocorticoid nuclear receptor variant 1, hERR1, hWALp4, heat shock protein family B (small) member 1, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), p39, p42-MAPK, p53 tumor suppressor, pMW1, pregnane X nuclear receptor variant 2, protein kinase, mitogen-activated, 1, protein kinase, mitogen-activated, 2, protein tyrosine kinase ERK2, tumor antigen p55, yadF